Healthcare | March 11, 2023
Build a sustainable healthcare and lifesciences industry, say Experts
Time to combine innovation, access and technology to deliver positive patient outcomes
Time to combine innovation, access and technology to deliver positive patient outcomes
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
FDA also accepts a separate supplemental application to extend prophylaxis with PREVYMIS to 200 days in certain HSCT recipients
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
Subscribe To Our Newsletter & Stay Updated
